Completed Cancer Infection & Immunity

Control of T cell responses by accessory receptors revealed by phenotypic models

In plain English

AI plain-English summary

T cells rely on a network of surface receptors to decide whether to attack a threat, but scientists still lack a reliable way to predict how the many "accessory" receptors—beyond the main T cell receptor—actually shape that decision. Current understanding treats these accessory receptors as simple on/off switches, either stimulating or inhibiting T cell activity. This binary view is too crude to explain why therapies like checkpoint inhibitors work in some patients but not others, or how to design better chimeric antigen receptor T cells for cancer. The researchers propose to bypass the usual biochemical assumptions by feeding T cell response data into a mathematical method called adaptive inference. This approach builds "phenotypic models" that reveal how accessory receptors actually integrate with T cell receptor signalling, without needing to know every molecular detail. If successful, the work will replace the stimulatory/inhibitory binary with a predictive framework that can guide T cell-based therapies. This is fundamental science—it does not promise an immediate treatment. But the same kind of mathematical modelling that now underpins weather forecasting and drug design could, here, give immunologists a tool to rationally engineer T cell responses rather than relying on trial and error.

View original technical description
T cells orchestrate immune responses crucial for the elimination of infections and cancers. They do this by initiating a diverse set of effector responses when their T cell surface receptors (TCRs) recognise these threats. It is now appreciated that a large number of other, “accessory”, receptors shape these responses. Indeed, the remarkable clinical success of checkpoint inhibitors and chimeric antigen receptors is based on perturbing accessory receptor signalling. Despite extensive research into the underlying biochemistry, we have yet to formulate canonical models of signalling that can predict how accessory receptors shape T cell responses. Here, we propose to use a mathematical method known as adaptive inference to identify signalling models directly from T cell response data, without prior biochemical assumptions. The method produces what we term "phenotypic models" because it coarse-grains over molecular information. These models provide effective pathway architectures showing how accessory receptors integrate (or not) with TCR signalling to shape response phenotypes. This will move the field beyond the current stimulatory/inhibitory binary paradigm of accessory receptors. The work offers a different way to study receptor regulated signalling pathways and the predictive power of the phenotypic model will be exploited for T cell-based therapies.

View the original record at the funder ↗

Researchers

Omer Dushek (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Predicting efficient T cell activation with therapeutic applications.
Discovering the Strategies T-Cells Employ for Robust Signal Integration using Mathematical Modelling and Machine Learning
Initiation, dynamic control and long-term consequences of T cell antigen receptor signalling: understanding etiology and therapy of immune diseases
Differential control of T cell co-stimulation by LFA-1, CD2, and CD28
Decision-making by lymphocytes

Original classification

Senior Research Fellowship Basic

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.